<DOC>
	<DOCNO>NCT00033774</DOCNO>
	<brief_summary>This study examine development stem cell ( immature cell produce bone marrow ) potential change cell organ type . These cell study potential use create replacement tissue diseases range diabetes Parkinson s. Healthy volunteer 18 year age old may eligible study . Candidates screen medical history , physical examination , blood test . Participants undergo process call 'stem cell mobilization apheresis ' collect bone marrow stem cell . For five day collection receive injection hormone call G-CSF , stimulate release stem cell bone marrow bloodstream . On fifth day injection , stem cell collect apheresis . For procedure , blood collect catheter ( plastic tube ) place arm vein direct cell separator machine . There , white cell stem cell separate blood component spin process collect bag inside machine . The rest blood return donor catheter arm .</brief_summary>
	<brief_title>Stem Cell Collection Adult Volunteers</brief_title>
	<detailed_description>The renewal various tissue organ steady state follow damage relies upon small population locally reside tissue specific `` stem cell '' Stem cell adult bone marrow represent ideal stem cell source base ease collection . In order begin explore potential adult bone marrow correction genetic disease affect blood sickle cell disease , propose vitro vivo mouse study examine regulation normal differentiation hematopoietic stem cell collect adult volunteer . In order obtain adult hematopoietic stem cell large number vitro vivo study , volunteer undergo mobilization G-CSF 5 consecutive day follow large volume apheresis 5th day G-CSF injection . The harvested product immunomagnetically purified primitive progenitor population viably cryopreserved multiple aliquot .</detailed_description>
	<criteria>INCLUSION CRITERIA : Age 18 great . Normal renal function : creatinine le than1.5 mg/dL , proteinuria less than1+ . Normal liver function : bilirubin le 2.5 mg/dL , ALT le 2.5 time upper limit normal , transminases less 2.5 time upper limit normal . Normal blood count : WBC 3,00010,000/mm3 , granulocyte great 1,500/mm3 , platelet great 150,000/mm3 , hemoglobin great 12.5g/dL , MCV within normal limit . Female volunteer childbearing age negative serum pregnancy test within one week begin GCSF administration . Meets NIH Department Transfusion Medicine ( DTM ) eligibility criterion blood component donation vitro research use ( negative serologic test syphilis , hepatitis B C , HIV , HTLV1 ) . Ability give inform consent participate protocol . EXCLUSION CRITERIA : Any underlie hematologic disorder include sickle cell disease . Active viral , bacterial , fungal , parasitic infection . History autoimmune disease , rheumatoid arthritis systemic lupus erythematosus . History cancer exclude squamous carcinoma skin cervical carcinoma situ . History cardiovascular disease relate symptom chest pain shortness breath . Any positive serum screen test list . Allergy GCSF bacterial E. coli product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 4, 2016</verification_date>
	<keyword>Leukapheresis</keyword>
	<keyword>G-CSF</keyword>
	<keyword>Mobilization</keyword>
	<keyword>Stem Cells</keyword>
	<keyword>Adult</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
	<keyword>Normal Control</keyword>
</DOC>